Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

18.96 +0.47 (+2.54%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Relay Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Relay Therapeutics Shares Are Getting Hammered ↗

September 13, 2022

Relay Therapeutics Inc (NASDAQ: RLAY) shares are trading lower by 11.33% to $25.54 Tuesday morning after the company priced a roughly 11.32 million share public offering of common stock at $26.50 per...

Via Benzinga

Relay Therapeutics, Rent the Runway And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 13, 2022

U.S. stock futures traded higher this morning ahead of the much-awaited inflation data for August. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket ↗

September 13, 2022

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average...

Via Benzinga

Dow, Nasdaq Futures Move Higher; All Eyes On Inflation Data ↗

September 13, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after recording gains on Monday. The Dow Jones surged around 230 points, while the Nasdaq Composite jumped more...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

Foundation Medicine and Relay Therapeutics Collaborate to Develop FoundationOne®CDx as a Companion Diagnostic for Relay’s Investigational FGFR2 Inhibitor, RLY-4008

September 12, 2022

From Foundation Medicine

Via Business Wire

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

September 08, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders.

Via Benzinga

AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday ↗

September 08, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Relay Therapeutics Shares Jump After Interim Data From Bile Duct Cancer Drug Ahead Of ESMO Presentation ↗

September 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022 ↗

September 02, 2022

Via Benzinga

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday ↗

September 02, 2022

Gainers

Via Benzinga

Relay Therapeutics Stock Shows Market Leadership With Jump To 94 RS Rating ↗

August 25, 2022

Relay Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 84 to 94.

Via Investor's Business Daily

Why Snowflake Is Trading Higher By 20%, Here Are 51 Stocks Moving In Thursday's Mid-Day Session ↗

August 25, 2022

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.

Via Benzinga

Salesforce, Dollar Tree, Tesla And Some Other Big Stocks Moving Lower On Thursday ↗

August 25, 2022

Peloton Interactive, Inc. (NASDAQ: PTON) shares fell 20.8% to $10.68 after the company reported worse-than-expected Q4 sales results and issued Q1 sales guidance below estimates.

Via Benzinga

Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday ↗

August 25, 2022

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.

Via Benzinga

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

Macy's, Palo Alto Networks And Other Big Gainers From Tuesday ↗

August 24, 2022

U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Looking Into Relay Therapeutics's Return On Capital Employed ↗

August 23, 2022

Relay Therapeutics (NASDAQ:RLAY) brought in sales totaling $365 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 23.76%, resulting in a loss of $76.79...

Via Benzinga

Gain Therapeutics: Reasons For Optimism ↗

August 09, 2022

In biotechnology, potential rules. And in Gain's case, the potential to not just treat but functionally cure at least some forms of Parkinson's Disease is strong enough to weather early-stage...

Via Talk Markets

Earnings Preview: Relay Therapeutics ↗

August 03, 2022

Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Relay...

Via Benzinga

Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights

July 28, 2022

From Relay Therapeutics, Inc.

Via GlobeNewswire

Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

Analyst Ratings for Relay Therapeutics ↗

June 06, 2022

Over the past 3 months, 4 analysts have published their opinion on Relay Therapeutics (NASDAQ:RLAY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...

Via Benzinga

Preview: Relay Therapeutics's Earnings ↗

May 04, 2022

Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Relay...

Via Benzinga

Best Biotech Stocks To Buy In 2022 ↗

March 15, 2022

Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...

Via Talk Markets

Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them? ↗

February 17, 2022

Can the formerly red-hot biotech segment return to its previous glory?

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 25, 2022

Gainers Anixa Biosciences (NASDAQ:ANIX) s...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.